Cargando…
Immunosuppressants and risk of Parkinson disease
We performed a population‐based case–control study of United States Medicare beneficiaries age 60–90 in 2009 with prescription data (48,295 incident Parkinson disease cases and 52,324 controls) to examine the risk of Parkinson disease in relation to use of immunosuppressants. Inosine monophosphate d...
Autores principales: | Racette, Brad A., Gross, Anat, Vouri, Scott Martin, Camacho‐Soto, Alejandra, Willis, Allison W., Searles Nielsen, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043771/ https://www.ncbi.nlm.nih.gov/pubmed/30009205 http://dx.doi.org/10.1002/acn3.580 |
Ejemplares similares
-
A comparison of prediction approaches for identifying prodromal Parkinson disease
por: Warden, Mark N., et al.
Publicado: (2021) -
Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries
por: Song, Yizhe, et al.
Publicado: (2023) -
Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries
por: Krzyzanowski, Brittany, et al.
Publicado: (2023) -
Validation of a Parkinson Disease Predictive Model in a Population-Based Study
por: Faust, Irene M., et al.
Publicado: (2020) -
Solvent exposed occupations and risk of Parkinson disease in Finland
por: Nielsen, Susan Searles, et al.
Publicado: (2021)